BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2009
View Archived Issues
Novel KSP inhibitors discovered by 4SC for cancer treatment
Read More
Bayer Schering Pharma discloses A1 receptor agonists for cardiovascular and other disorders
Read More
Santhera completes enrollment in RHODOS clinical study of Catena in LHON
Read More
Vical and Teva sign agreement for sales and marketing of Allovectin-7 in Israel
Read More
Invega approved for the treatment of schizoaffective disorder
Read More
Novel nucleotide analogues described by Alios Biopharma
Read More
Palau Pharma developing novel histamine H4 receptor antagonists
Read More
Novel antibacterial agents in early development at Shionogi
Read More
Debiopharm and MSM sign development and commercialization agreement for Debio-0929
Read More
Kringle concludes dosing and safety evaluation in phase Ia trial of rhHGF in renal disease
Read More
Human embryonic stem cell-derived motor neuron progenitors for clinical application
Read More
EMD-273063 shows biological activity in phase I/II trial in metastatic malignant melanoma
Read More
Lexicon initiates phase II clinical trial of S1P inhibitor LX-2931 in RA
Read More
FDA grants orphan drug designation to DOR's orBec for chronic gastrointestinal GVHD
Read More
Monotherapy data reported for lersivirine in HIV-1 infected subjects
Read More
BI-2536 monotherapy shows no activity in phase II trial in patients with SCLC
Read More
Fuso and OncoTherapy initiate phase II study of OTS-102 for biliary cancer
Read More
Deferoxamine reduces brain edema and neuronal death in a rat model of SAH
Read More
NeuroSearch completes preclinical development of GABA-A receptor modulator NSD-721
Read More
FDA approves SPA for Keryx's phase III trial of perifosine in multiple myeloma
Read More
Bionovo reports results from phase Ib clinical trial of Bezielle in advanced breast cancer
Read More
Napo completes dose selection stage of ADVENT trial of crofelemer in HIV/AIDS
Read More
Adventrx to submit an NDA for vinorelbine emulsion by the end of 2009
Read More
EpiCept files Ceplene NDS with Health Canada for AML patients in first complete remission
Read More
Nile initiates dosing in phase II clinical study of CD-NP for acute heart failure
Read More
